Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Gains from Investment Securities (2018 - 2025)

Historic Gains from Investment Securities for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to -$1.9 million.

  • Health Catalyst's Gains from Investment Securities fell 1540.8% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.5 million, marking a year-over-year decrease of 100460.36%. This contributed to the annual value of -$1.6 million for FY2024, which is 18076.73% down from last year.
  • According to the latest figures from Q3 2025, Health Catalyst's Gains from Investment Securities is -$1.9 million, which was down 1540.8% from -$1.6 million recorded in Q3 2024.
  • In the past 5 years, Health Catalyst's Gains from Investment Securities registered a high of $6.9 million during Q2 2021, and its lowest value of -$8.4 million during Q1 2022.
  • In the last 5 years, Health Catalyst's Gains from Investment Securities had a median value of $2.1 million in 2021 and averaged $1.4 million.
  • In the last 5 years, Health Catalyst's Gains from Investment Securities skyrocketed by 70055.71% in 2021 and then tumbled by 49072.36% in 2022.
  • Health Catalyst's Gains from Investment Securities (Quarter) stood at $6.4 million in 2021, then tumbled by 58.71% to $2.6 million in 2022, then decreased by 22.85% to $2.0 million in 2023, then crashed by 180.77% to -$1.6 million in 2024, then dropped by 15.41% to -$1.9 million in 2025.
  • Its last three reported values are -$1.9 million in Q3 2025, -$1.6 million for Q3 2024, and $2.0 million during Q2 2023.